Melinda Merchant, MD, PHD

Normunity – Chief Medical Officer

Dr. Merchant is Chief Medical Officer at Normunity Inc, a company established to pioneer cancer-fighting medicines that target novel immuno-oncology mechanisms. A board-certified Pediatric Hematologist and Oncologist with a PhD in Immunology, Dr. Merchant held previous physician-scientist positions at the National Cancer Institute (NCI) and Memorial Sloan-Kettering Cancer Center with a focus on sarcomas and immunotherapy. She is the former VP of Early Stage Development at Epizyme where she led Translational Medicine and Early Clinical Development.

Dr. Merchant earned her MD and PhD at the University of Miami School of Medicine and Department of Immunology & Microbiology, trained in pediatrics at Children’s National Medical Center, and completed her fellowship at the National Cancer Institute in a combined program with Johns Hopkins Hospital.